Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing.
Raposo M, Bettencourt C, Melo ARV, Ferreira AF, Alonso I, Silva P, Vasconcelos J, Kay T, Saraiva-Pereira ML, Costa MD, Vilasboas-Campos D, Bettencourt BF, Bruges-Armas J, Houlden H, Heutink P, Jardim LB, Sequeiros J, Maciel P, Lima M. Raposo M, et al. Among authors: vilasboas campos d. Neurobiol Dis. 2022 Jan;162:105578. doi: 10.1016/j.nbd.2021.105578. Epub 2021 Dec 3. Neurobiol Dis. 2022. PMID: 34871736 Free article.
Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease.
Pereira-Sousa J, Ferreira-Lomba B, Bellver-Sanchis A, Vilasboas-Campos D, Fernandes JH, Costa MD, Varney MA, Newman-Tancredi A, Maciel P, Teixeira-Castro A. Pereira-Sousa J, et al. Among authors: vilasboas campos d. Neurobiol Dis. 2021 May;152:105278. doi: 10.1016/j.nbd.2021.105278. Epub 2021 Jan 28. Neurobiol Dis. 2021. PMID: 33516872 Free article.
Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D2 and Serotonin 1A and 2A Receptors in C. elegans.
Jalles A, Vieira C, Pereira-Sousa J, Vilasboas-Campos D, Mota AF, Vasconcelos S, Ferreira-Lomba B, Costa MD, Da Silva JD, Maciel P, Teixeira-Castro A. Jalles A, et al. Among authors: vilasboas campos d. Biomedicines. 2022 Feb 3;10(2):370. doi: 10.3390/biomedicines10020370. Biomedicines. 2022. PMID: 35203579 Free PMC article.
Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation.
Figueiredo F, Sárkány Z, Silva A, Vilasboas-Campos D, Maciel P, Teixeira-Castro A, Martins PM, Macedo-Ribeiro S. Figueiredo F, et al. Among authors: vilasboas campos d. Biomed Pharmacother. 2023 Sep;165:115258. doi: 10.1016/j.biopha.2023.115258. Epub 2023 Aug 5. Biomed Pharmacother. 2023. PMID: 37549460 Free article.
Differential impact of diesel exhaust particles on glutamatergic and dopaminergic neurons in Caenorhabditis elegans: A neurodegenerative perspective.
Chatterjee N, González-Durruthy M, Costa MD, Ribeiro AR, Vilas-Boas V, Vilasboas-Campos D, Maciel P, Alfaro-Moreno E. Chatterjee N, et al. Among authors: vilasboas campos d. Environ Int. 2024 Apr;186:108597. doi: 10.1016/j.envint.2024.108597. Epub 2024 Mar 22. Environ Int. 2024. PMID: 38579453 Free article.
Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3.
Duarte-Silva S, Da Silva JD, Monteiro-Fernandes D, Costa MD, Neves-Carvalho A, Raposo M, Soares-Cunha C, Correia JS, Nogueira-Goncalves G, Fernandes HS, Oliveira S, Ferreira-Fernandes AR, Rodrigues F, Pereira-Sousa J, Vilasboas-Campos D, Guerreiro S, Campos J, Meireles-Costa L, Rodrigues CMP, Cabantous S, Sousa SF, Lima M, Teixeira-Castro A, Maciel P. Duarte-Silva S, et al. Among authors: vilasboas campos d. J Clin Invest. 2024 Mar 1;134(5):e162246. doi: 10.1172/JCI162246. J Clin Invest. 2024. PMID: 38227368 Free PMC article.